Page last updated: 2024-08-26

16-dehydropregnenolone and Benign Neoplasms

16-dehydropregnenolone has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bratoeff, E; Cabeza, M; Heuze, Y; Ramírez-Apan, T; Sánchez, A; Silva-Ortiz, AV; Soriano, J1

Other Studies

1 other study(ies) available for 16-dehydropregnenolone and Benign Neoplasms

ArticleYear
Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1.
    Bioorganic & medicinal chemistry, 2015, Dec-15, Volume: 23, Issue:24

    Topics: 5-alpha Reductase Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cholestenone 5 alpha-Reductase; Humans; Male; Mesocricetus; Neoplasms; Pregnenolone; Rats

2015